C9 Antibody
-
中文名稱:C9兔多克隆抗體
-
貨號(hào):CSB-PA004259LA01HU
-
規(guī)格:¥440
-
圖片:
-
Immunohistochemistry of paraffin-embedded human liver tissue using CSB-PA004259LA01HU at dilution of 1:100
-
Immunohistochemistry of paraffin-embedded human spleen tissue using CSB-PA004259LA01HU at dilution of 1:100
-
Immunofluorescent analysis of HepG2 cells using CSB-PA004259LA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)
-
-
其他:
產(chǎn)品詳情
-
產(chǎn)品名稱:Rabbit anti-Homo sapiens (Human) C9 Polyclonal antibody
-
Uniprot No.:
-
基因名:
-
別名:C9; Complement component C9
-
宿主:Rabbit
-
反應(yīng)種屬:Human
-
免疫原:Recombinant Human Complement component C9 protein (74-155AA)
-
免疫原種屬:Homo sapiens (Human)
-
標(biāo)記方式:Non-conjugated
本頁面中的產(chǎn)品,C9 Antibody (CSB-PA004259LA01HU),的標(biāo)記方式是Non-conjugated。對(duì)于C9 Antibody,我們還提供其他標(biāo)記。見下表:
-
克隆類型:Polyclonal
-
抗體亞型:IgG
-
純化方式:>95%, Protein G purified
-
濃度:It differs from different batches. Please contact us to confirm it.
-
保存緩沖液:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
產(chǎn)品提供形式:Liquid
-
應(yīng)用范圍:ELISA, IHC, IF
-
推薦稀釋比:
Application Recommended Dilution IHC 1:20-1:200 IF 1:50-1:200 -
Protocols:
-
儲(chǔ)存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關(guān)產(chǎn)品
靶點(diǎn)詳情
-
功能:Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C9 is the pore-forming subunit of the MAC.
-
基因功能參考文獻(xiàn):
- The data supports the assumption that C9 gene expression may stimulate the expression of inflammatory (NLRP3) and angiogenic growth factors (VEGF) in retinal pigment epithelial cells. PMID: 30090015
- Serum-expressed apolipoprotein B-100 protein, C9 Complement, and gelsolin can be used for differential diagnosis of Barrertts esophagus and adenocarcinoma of esophagus. PMID: 26404905
- Data indicate that complement C9 binds to the ATPase domain of mortalin. PMID: 24719326
- Liver biopsy specimens from chronically hepatitis C virus-infected patients exhibited a lower level of C9 mRNA expression than liver biopsy specimens from unrelated disease or healthy control human liver RNA. PMID: 23487461
- the haploinsufficiency of C9, a terminal complement complex component, engenders reduced intraocular secretion of VEGF and decreased risk for CNV development. PMID: 22190594
- C9 and fucosylated form could serve as a useful marker for SQLC. PMID: 21840429
- It was concluded that variations in the complement component 9 gene are unlikely to influence clearance of chronic hepatitis B virus infection and hepatocellular carcinoma occurrence. PMID: 21380615
- Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9. PMID: 21507937
- These results suggested that the lack of membrane attack complex because of an Arg95Stop mutation of the complement component 9 gene predisposed patients to pathognomonic glomerulonephritis. PMID: 21057849
- provided evidence for the recognition of membrane-bound C9 on complement-lysed ghosts by an antibody specific for the helix-turn-helix fold. PMID: 20153530
- Data show that mortalin supports cancer cell resistance to complement-dependent cytotoxicity and suggest consideration of mortalin as a novel target for cancer adjuvant immunotherapy. PMID: 19739077
- The human complement C9 gene: structural analysis of the 5' gene region and genetic polymorphism studies. PMID: 11881818
- C9 binding is dependent on the N-terminal modules (thrombospondin type 1 and low-density lipoprotein receptor class A) of C8 alpha together with the C8 alpha membrane attack complex/perforin domain. PMID: 12463754
- Founder effect was demonstrated for the R95X mutation of the C9 gene in Japanese PMID: 12596049
- results indicate that the principal binding site for C9 lies within the MACPF domain of C8alpha PMID: 16618117
- analysis of the CD59-C9 binding interaction PMID: 16844690
顯示更多
收起更多
-
相關(guān)疾?。?/div>Complement component 9 deficiency (C9D); Macular degeneration, age-related, 15 (ARMD15)亞細(xì)胞定位:Secreted. Target cell membrane; Multi-pass membrane protein.蛋白家族:Complement C6/C7/C8/C9 family組織特異性:Plasma (at protein level).數(shù)據(jù)庫鏈接:
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-